Glenmark Pharmaceuticals acquires and launches acetylcysteine injection
Glenmark Pharmaceuticals USA announces the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) single-dose vials. Glenmark’s Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) single-dose vials can be…